News

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

  • New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy
    06/27/2024

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

  • Late clinical-stage company to provide update on Phase 3 treatment for celiac disease Late clinical-stage company to provide update on Phase 3 treatment for celiac disease
    05/22/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

The price of (ENTO) is 0.9497 and it was updated on 2024-07-15 13:00:34.

Currently (ENTO) is in undervalued.

Unlock
ENTO Ratings Summary
ENTO Quant Ranking